Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

GSK

3 posts
GGlencore
British Business Headlines: GSK Investment, Burberry Stake, AstraZeneca Challenges, Glencore Allegations, Football Deal Talks
Read More

British Business Headlines: GSK Investment, Burberry Stake, AstraZeneca Challenges, Glencore Allegations, Football Deal Talks

  • 2026-07-29
In a significant economic development, pharma giant GSK announced plans to establish a global research and development headquarters…
RRoche
Roche CEO Schinecker Warns Swiss Pharma Is Losing Its Edge as $15.2 Billion China Deals Redraw the Map — BigGo Finance
Read More

Roche CEO Schinecker Warns Swiss Pharma Is Losing Its Edge as $15.2 Billion China Deals Redraw the Map — BigGo Finance

  • 2026-07-06
Novo Nordisk just launched the most commercially successful weight-loss drug in history — and it costs less per…
RRoche
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer
Read More

GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer

  • 2026-06-11
GSK has struck a deal to buy Nuvalent for $10.6 billion, securing two near-approval cancer therapies that could challenge…
Switzerland
www.europesays.com